Alexandria at Torrey Pines – Illumina Theatre
10996 Torreyana Road
San Diego, CA 92121

$25 per person; registration is required.

Panelists:

Kim Kamdar, PhD, Managing Partner at Medical Excellence Capital, a life sciences venture capital firm focused on early stage investing. She has also been a long-term Partner at Domain Associates. She is currently Chairman of the Board of Directors of Sera Prognostics (NASDAQ: SERA) and is co-founder and Chair of Seraphina Therapeutics and Truvian Sciences. She also serves on the board of directors of Alume, Epic Sciences, Pleno and Singular Genomics (NASDAQ: OMIC).

Richard A. Heyman, PhD, Co-founder and Chairman of ArCHitect Therapeutics, a small molecule drug discovery company applying novel chemical editing technologies to expand the druggable space. He is co-founder and Chairman of ORIC Pharmaceuticals and serves as Chairman of Rayze Bio, Enliven Therapeutics, PMV Pharma and a BOD member for the Vividion/Bayer ongoing joint venture.

Sheila Gujrathi, MD, a biotech entrepreneur and executive, healthcare investor, and drug developer with over 25 years of experience in the biotech and pharmaceutical industries. She serves as executive chair of the board of directors of Ventyx Biosciences, Inc., chair of ADARx Pharmaceuticals, Inc., chair of ImmPACT Bio, Inc. and director of Janux Therapeutics, Inc.

Moderated by Sylvia Tara, PhD, with over 20 years of experience in biotechnology and pharmaceuticals, including McKinsey & Company, Genentech, Amgen and Abbvie